These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9531048)
1. Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop. Debrock S; Declerck PJ Thromb Haemost; 1998 Mar; 79(3):597-601. PubMed ID: 9531048 [TBL] [Abstract][Full Text] [Related]
2. Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F. Schousboe SL; Egelund R; Kirkegaard T; Preissner KT; Rodenburg KW; Andreasen PA Thromb Haemost; 2000 May; 83(5):742-51. PubMed ID: 10823273 [TBL] [Abstract][Full Text] [Related]
3. High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I). Stoop AA; Jespers L; Lasters I; Eldering E; Pannekoek H J Mol Biol; 2000 Sep; 301(5):1135-47. PubMed ID: 10966811 [TBL] [Abstract][Full Text] [Related]
4. Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein. Smolarczyk K; Gils A; Boncela J; Declerck PJ; Cierniewski CS Biochemistry; 2005 Sep; 44(37):12384-90. PubMed ID: 16156651 [TBL] [Abstract][Full Text] [Related]
5. Importance of N-terminal residues in plasminogen activator inhibitor 1 on its antibody induced latency transition. Ngo TH; Zhou Y; Stassen JM; Declerck PJ Thromb Haemost; 2002 Aug; 88(2):288-93. PubMed ID: 12195702 [TBL] [Abstract][Full Text] [Related]
6. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Gils A; Knockaert I; Declerck PJ Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525 [TBL] [Abstract][Full Text] [Related]
7. A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state. Mathiasen L; Dupont DM; Christensen A; Blouse GE; Jensen JK; Gils A; Declerck PJ; Wind T; Andreasen PA Mol Pharmacol; 2008 Sep; 74(3):641-53. PubMed ID: 18559377 [TBL] [Abstract][Full Text] [Related]
8. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis. Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948 [TBL] [Abstract][Full Text] [Related]
9. Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1. Bijnens AP; Ngo TH; Gils A; Dewaele J; Knockaert I; Stassen JM; Declerck PJ Thromb Haemost; 2001 May; 85(5):866-74. PubMed ID: 11372681 [TBL] [Abstract][Full Text] [Related]
10. Identification of a structural epitope by using a peptide library displayed on filamentous bacteriophage. Hoess RH; Mack AJ; Walton H; Reilly TM J Immunol; 1994 Jul; 153(2):724-9. PubMed ID: 7517422 [TBL] [Abstract][Full Text] [Related]
11. Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding. Wind T; Jensen MA; Andreasen PA Eur J Biochem; 2001 Feb; 268(4):1095-106. PubMed ID: 11179976 [TBL] [Abstract][Full Text] [Related]
12. Importance of the hinge region between alpha-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies. Bijnens AP; Gils A; Knockaert I; Stassen JM; Declerck PJ J Biol Chem; 2000 Mar; 275(9):6375-80. PubMed ID: 10692438 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421 [TBL] [Abstract][Full Text] [Related]
14. [Plasminogen activator-inhibitor 1: biochemical, structural and functional studies]. Declerck P Verh K Acad Geneeskd Belg; 1993; 55(5):457-73. PubMed ID: 8128782 [TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity. Jankun J; Specht Z; Szkudlarek M; Greenfield R; Gaikwad B; Trifonov L; Vaugeois J; Aleem AM; Basrur V; Selman SH; Zavodszky MI; Skrzypczak-Jankun E Int J Mol Med; 2006 Mar; 17(3):437-47. PubMed ID: 16465390 [TBL] [Abstract][Full Text] [Related]